We are live on
!
Find out more
SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
209 hedge funds and large institutions have $2.91B invested in SpringWorks Therapeutics in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 95 increasing their positions, 55 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
73% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 55
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1.93% less ownership
Funds ownership: 106.09% → 104.16% (-1.9%)
4% less funds holding
Funds holding: 217 → 209 (-8)
16% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 37
25% less capital invested
Capital invested by funds: $3.85B → $2.91B (-$945M)
86% less call options, than puts
Call options by funds: $1.59M | Put options by funds: $11.8M
Holders
209
Holders Change
-8
Holders Change %
-3.69%
% of All Funds
3.02%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
31
Increased
95
Reduced
55
Closed
37
Calls
$1.59M
Puts
$11.8M
Net Calls
-$10.2M
Net Calls Change
-$37.5M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$73.3M |
| 2 |
DM
Deerfield Management
New York
|
-$63.2M |
| 3 |
Millennium Management
New York
|
-$29.1M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$26.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$25.8M |
